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Background/Objectives: Paraneoplastic pemphigus (PNP) is a rare mucocutaneous disease with a high
mortality rate. It is deﬁned by polymorphic mucocutaneous manifestations, particular histological fea-
tures, characteristic results of direct and indirect immunoﬂuorescence examinations, presences of spe-
ciﬁc autoantibodies, and associations with underlying neoplasms. However, currently, there is no
existing study regarding the characteristics of PNP patients in Taiwan. In this study, we report a case
series and try to determine the speciﬁc presentations of PNP patients in Taiwan.
Materials and methods: PNP patients treated in a referral center in northern Taiwan from 1998 to 2012
were retrospectively recruited. The clinical manifestations, histopathological features, ﬁndings of direct
and indirect immunoﬂuorescence, results of immunoblotting, and all relevant clinical information were
collected.
Results: Eleven patients were identiﬁed with an average age of 62 years. Polymorphic mucocutaneous
manifestations were observed in almost all patients. The most common presentation was pemphigus-
like lesions, followed by lichen planus-like lesions. All patients had recalcitrant oral mucosal lesions.
Five and four patients had genital and eye involvements, respectively. The mostly associated neoplasm is
Castleman’s disease, followed by malignant thymoma. Acantholysis is the mostly observed histological
features, followed by lichenoid dermatitis and interface dermatitis. Depositions of immunoglobulins or
complements on the surface of keratinocytes or along basement membrane zone were found in eight and
seven patients, respectively. Respiratory symptoms presented in eight patients. Despite intensive
treatments, seven patients expired.
Conclusion: PNP in Taiwanese patients has a high association with Castleman’s disease or malignant
thymoma. Complete laboratory examinations and thorough investigations for occult neoplasms are
mandatory to establish a diagnosis in patients with clinical suspicions of PNP.
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Paraneoplastic pemphigus (PNP), ﬁrst reported by Anhalt et al1 in
1990, is a rare mucocutaneous disease with a very high mortality
rate. Clinically, it is characterized by severe mucositis with poly-
morphic skin eruptions, occurring in patients with concomitant
neoplasms. In the literature, most common associated neoplasms
were lymphoid neoplasms, including non-Hodgkin’s lymphoma,
chronic lymphocytic leukemia, and Castleman’s disease.2,3y have no ﬁnancial or non-
tter or materials discussed in
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iwanese Dermatological AssociatioIn addition, several features, including: histopathologic exami-
nation showing acantholysis and interface dermatitis; positive
direct immunoﬂuorescence (DIF) ﬁndings at the keratinocyte cell
surfaces and/or along the basement membrane zone (BMZ); posi-
tive indirect immunoﬂuorescence (IIF) results using different
epithelia; and serum immunoblotting (IB) revealing a complex of
ﬁve proteins of 250 kD, 230 kD, 210 kD, 190 kD, and 170 kD are
demonstrated to be characteristic for PNP.4 Among them, the as-
sociation with a lymphoid neoplasm, positive IIF results on rat
bladder, and recognition of envoplakin (210 kD) and/or periplakin
(190 kD) upon IB are the most sensitive and speciﬁc features in the
diagnosis of PNP.5
However, depositions of PNP autoantibodies were found in
many tissues other than skin and epithelium, including kidney,
urinary bladder, and muscles.6 At least ﬁve different clinical and
immunopathological variants have been identiﬁed, includingn. Published by Elsevier Taiwan LLC. All rights reserved.
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graft-versus-host disease-like, and lichen planus (LP)-like. There-
fore, Nguyan et al.6 proposed a more encompassing term “para-
neoplastic autoimmune multiorgan syndrome”. In addition, several
unusual cases were reported, including patients without a under-
lying neoplasm,7 patients with lichenoid eruptions without
detectable autoantibodies,8 and patients without mucosal
involvement.9 All of these emphasize the complexity of the disease,
the variety of mucocutaneous presentations and organ in-
volvements, and the need for further investigations.
To date, only a few case series have been reported in the liter-
ature due to the rarity of the disease. In this study, we retrospec-
tively collected PNP patients in a referral center in northern Taiwan
and analyzed the characteristics of this rare disease in the domestic
region.
Materials and methods
Patientswith PNP treated in theNational TaiwanUniversityHospital
from 1998 to 2012 were retrospectively recruited. The diagnosis of
PNP was according to the criteria proposed by Camisa and Helm,10
including major criteria and minor criteria. Major criteria include
polymorphous mucocutaneous eruption, concurrent internal
neoplasia, and characteristic serum immunoprecipitation ﬁndings.
Minor criteria include positive cytoplasmic staining of rat bladder
epithelium by IIF, intercellular and BMZ immunoreactants on DIF of
perilesional tissue, andacantholysis inbiopsy specimen fromat least
one anatomic site of involvement. To be diagnosed with PNP, pa-
tients must fulﬁll three major or two major and two minor criteria.
For patients presented with the lichenoid variant of PNP not
meeting the Camisa and Helm’s criteria, we used the criteria pro-
posed by Cummins et al,8 which include the following: (1) known
or occult neoplasm; (2) extensive, refractory mucous membrane
ulcerations; (3) histologic examination for mucosa or skin revealing
lichenoid interface dermatitis; and (4) lichenoid or polymorphous
blistering skin lesions and/or pulmonary involvement consistent
with bronchiolitis obliterans (BO).
The demographic data, associated malignancies, presentations
of cutaneous lesions, presences of mucosal involvements, histo-
pathological features, results of DIF and IIF, ﬁndings of IB, systemic
symptoms, treatments, complications, and outcomes of all the pa-
tients were collected.
Results
Patient characteristics
Eleven patients were recruited into this study. All patients fulﬁlled
the Camisa and Helm criteria except two cases (Cases 9 and 11),
who presented with severe mucositis with predominant lichenoid
skin eruptions, met the Cummin’s criteria and were diagnosed as
lichenoid variant of PNP. The average age was 62 years (range, 30e
86 years). Seven patients were male. The development of muco-
cutaneous lesions prior to or concomitant with the diagnosis of
underlying neoplasms was noted in six patients. Others presented
with mucocutaneous manifestations months or years after the
diagnosis of underlying neoplasms being made.
Associated neoplasms
All patients had at least one neoplasm. Two of them had two
concomitant neoplasms. The most common associated neoplasm
was Castleman’s disease (4 cases, 36%), followed by malignant
thymoma (3 cases, 27%), follicular dendritic cell sarcoma (2 cases,
18%), and non-Hodgkin’s lymphoma (2 cases, 18%). Most associatedneoplasms were lymphoid neoplasms. Solid organ neoplasms were
only encountered in two patients. One was squamous cell carci-
noma of the lung, and the other was thyroid papillary micro-
carcinoma. For those presenting with concomitant neoplasms, one
had follicular dendritic cell sarcoma arising from Castleman’s dis-
ease, and the other had both malignant thymoma and thyroid
papillary microcarcinoma.
Mucocutaneous manifestations
Mucocutaneous manifestations of the patients were polymorphic
(Figure 1 and Table 1). All patients except one had more than one
kind of mucocutaneous lesion. The most common presentationwas
pemphigus-like, widespread, crusted erosions and ulcerations
(Figure 1A), which were observed in nine patients (82%).
Pemphigoid-like lesions such as hemorrhagic blisters on the palms
were only occasionally found (Figure 1B). Inﬁltrative, purpuric,
polygonal, ﬂat-topped papules and plaques (Figure 1C) or erosive
lichenoid papules and plaques (Figure 1D) were the second most
common feature and were found in eight patients (73%). Few pa-
tients also presented with erythema multiforme (EM)-like targe-
toid lesions. Pemphigus-like lesions were the predominant
manifestations in six patients, while LP-like lesions were the pre-
dominant presentations in the other ﬁve patients.
All patients had extensive, refractory oral mucositis, involving
lips, buccal mucosae, and tongues (Figure 1E). Genital erosions
were found in ﬁve patients (45%; Figure 1F), and eye involvements
were observed in four patients (36%; Figure 1G). In addition, other
less common manifestations were also encountered, including
paronychia (Figure 1H) and anonychia (Figure 1I).
Histopathology and immunopathology
The patterns of histopathology varied and depended on the type of
cutaneous lesions being sampled. Seven of the patients received
more than two skin biopsies. Of all the skin biopsies, acantholysis
(Figure 2A), including suprabasal acantholysis or intraepithelial
acantholysis, was mostly observed and presented in nine patients
(82%). Lichenoid dermatitis (Figure 2B), that was lichenoid inﬁl-
tration with apoptotic keratinocytes, was noted in skin specimen
from six patients (55%). Interface dermatitis, which was basal
vacuolar change with apoptotic keratinocytes (Figure 2C), was
found in skin specimen from three patients (27%). Not surprisingly,
to perform a clinico-pathological correlation, acantholysis was
mostly found in pemphigus-like lesions and lichenoid dermatitis or
interface dermatitis was mostly observed in clinically LP-like or
EM-like lesions, respectively.
For patterns of DIF ﬁndings, deposition of immunoglobulins or
complement on the surface of keratinocytes (Figure 2D) was found
in eight patients (73%). Linear deposition of immunoglobulins or
complement along the BMZ (Figure 2E) was noted in seven patients
(64%). Immunoglobulin M (IgM) cytoid bodies (Figure 2F) were
observed in three patients (27%) having LP-like lesions. For results
of IIF ﬁndings, eight patients (73%) had positive serum anti-
intercellular substance (ICS) antibodies using monkey esophagus
as the substrates. Two of them also received IIF examinations using
rat bladder as the substrates and had positive staining on the
epithelium of the bladder. No patients had detectable anti-BMZ
antibodies in their sera.
Immunoblotting
Immunoblotting of serum samples were performed in ﬁve patients
(Table 1). Two patients had all characteristic bands corresponding
to proteins of 250 kD, 230 kD, 210 kD, 190 kD, and 170 kD. One had
Table 1 Summary of the patients.
No. Age Sex Cutaneous
lesionsa
Mucosa Associated
neoplasms
Pathologyb DIF IIF IB
O G E
1 30 M LP, PV þ þ  CD, FDCS Acantholysis
Lichenoid dermatitis
IgG: ICSþ
IgM: cytoid bodyþ
ICSþ 170, 190, 210, 230, 250
2 51 F PV, EM þ  þ NHL Acantholysis IgG: ICSþ
C3: BMZþ, linear
ICSþ 40
3 57 F PV, EM þ   CD Acantholysis
Interface dermatitis
IgG, IgA, C3: ICSþ
IgM: BMZþ, linear
ICSþ (bladderþ) 230, 250
4 77 F LP, PV þ   CD Acantholysis
Interface dermatitis
IgM: cytoid bodyþ ICSþ 170, 190, 210, 230, 250
5 72 M LP, EM þ  þ CD Acantholysis (focal)
Lichenoid dermatitis
IgG, IgA, C3: ICSþ
IgM: BMZþ, linear
ICSþ NA
6 62 M PF, LP þ þ þ Thymoma Acantholysis
Lichenoid dermatitis
IgG: ICSþ
C3: BMZþ, linear
ICSþ 190, 210
7 48 F PV, LP þ þ  FDCS Acantholysis
Lichenoid dermatitis
IgG: ICSþ
C3: BMZþ, linear
Nil NA
8 72 M LP þ   Thymoma Lichenoid dermatitis IgM: cytoid body ICSþ NA
9 86 M PV, LP þ þ þ Lung SCC Acantholysis IgG: ICSþ
C3: BMZþ, linear
ICSþ (bladderþ) NA
10 76 M PV, EM þ   NHL Acantholysis
Interface dermatitis
IgG: ICSþ
C3: BMZþ, linear
Nil NA
11 51 M LP, PV þ þ  Thymoma
Thyroid Ca
Lichenoid dermatitis NA Nil NA
BMZ ¼ basement membrane zone; BP ¼ bullous pemphigoid; C3 ¼ complement 3; CD ¼ Castleman’s disease; DIF ¼ direct immunoﬂuorescence; E ¼ eye; EM ¼ erythema
multiforme; F ¼ female; FDCS ¼ follicular dendritic cell sarcoma; G ¼ genital; IB ¼ immunoblotting; ICS ¼ intercellular substance; IgA ¼ immunoglobulin A;
IgG ¼ immunoglobulin G; IgM ¼ immunoglobulin M; IIF ¼ indirect immunoﬂuorescence; LP ¼ lichen planus; M ¼ male; NA ¼ not applicable; NHL ¼ non-Hodgkin’s lym-
phoma; O ¼ oral; PF ¼ pemphigus foliaceus; PV ¼ pemphigus vulgaris; Thyroid Ca ¼ thyroid papillary microcarcinoma.
a The order of the lesions listed in the column is based on the order of predominance in the individual patient
b Interface dermatitis is deﬁned as a feature of basal vacuolation with dyskeratotic cells, while lichenoid dermatitis is applied to the ﬁnding composed of a dense band-like
inﬁltration at upper dermis along with basal vacuolation and dyskeratotic cells.
Figure 1 Clinical presentations of patients with paraneoplastic pemphigus. (A) Pemphigus-like, widely distributed, crusted erosions on the trunk in Case 9; (B) hemorrhagic blisters
on the palms in Case 10; (C) numerous lichen planus-like, erythematous or purplish, ﬂat-topped, papules and plaques on the trunk in Case 5; (D) crusted erosive papules and
plaques, which healed with residual hyperpigmentations, on the palms in Case 1; (E) recalcitrant crusted erosions and ulcers on the lips and the tongue in Case 8; (F) several
erosions on the glans penis in Case 5; (G) corneal perforation in Case 6; (H) paronychia on the big toe in Case 11; and (I) anonychia affecting all ﬁnger nails in Case 1.
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Figure 2 Histopathologic and immunohistologic features of patients with paraneoplastic pemphigus. (A) suprabasal acantholysis with a typical tombstone appearance; (B)
lichenoid inﬁltrations with numerous apoptotic keratinocytes and cleft formation in a specimen taken from a lip; (C) interface dermatitis with basal vacuolar changes and numerous
apoptotic keratinocytes; (D) depositions of immunoglobulin G on the surface of keratinocytes; (E) depositions of complements on the basement membrane zone; and (F) de-
positions of immunoglobulin M cytoid bodies at the papillary dermis.
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bands of 190 kD and 210 kD proteins, and another had only one
band that reacted with the 40 kD protein.
Respiratory involvement and complications
In addition to mucocutaneous manifestations, systemic symptoms
and complications occurred frequently in PNP patients (Table 2).
Respiratory symptoms, including dry cough and dyspnea, were
reported in eight patients (73%). Nevertheless, a diagnosis of BO
was conﬁrmed in only four patients (36%). Systemic infections were
the mostly encountered complications during the period of treat-
ment, including disseminated tuberculosis, cryptococcemia,
disseminated cytomegalovirus (CMV) infection, and herpetic
keratitis. Two of the four above-mentioned patients with eyeTable 2 Treatment, complications, and prognosis of the patients.
Case Respiratory
symptoms
BO Treatment Treatment
for
neoplasm
Prognosis and
follow-up
duration (Mo)
Note
1 þ  CS S, C/T Survived, 58 Anonychia
2 þ þ CS, RTX S, C/T Died, 11 Tuberculosis
3   CS, IVIG Nil Died, 24 Cryptococcemia
4 D þ CS, IVIG S Died, 9 Nil
5 þ þ CS S Died, 8 Corneal
perforation
6 þ  CS, CYC,
AZA
S Died, 4 Corneal
perforation,
CMV
7   CS, CYC,
IVIG
S, C/T Survived, 69 Nil
8   CS S, R/T Survived, 59 Hip fracture
9 þ  CS C/T Died, 14 Herpetic
keratitis
10 þ þ CS, RTX C/T Died, 1 Nil
11 þ  CS, PE,
AZA
S Survived, 12 Myasthenia
gravis
AZA ¼ azathioprine; BO ¼ bronchiolitis obliterans; C/T ¼ chemotherapy;
CMV ¼ cytomegalovirus infection; CS ¼ corticosteroids; CYC ¼ cyclophosphamide;
IVIG ¼ intravenous immunoglobulin; Mo ¼ month; PE ¼ plasma exchange;
RTX ¼ rituximab; R/T ¼ radiotherapy; S ¼ surgery.involvement had severe corneal perforations (Figure 1G) and
needed to receive amniotic membrane transplantations to restore
their visual acuity.
Treatment and prognosis
All patients received high dose of systemic corticosteroids (Table 2).
The maximal daily dosage was 2e4 mg/kg body weight. Intrave-
nous immunoglobulin was used in three patients with a dosage of
2 g/kg body weight. Rituximab infusions with a dosage of 375 mg/
m2 body surface areawere performed in two patients. Both patients
had underlying lymphomas. Cyclophosphamide and azathioprine
were both used in two of the patients. For treatments of underlying
neoplasms, surgical interventions were performed in eight patients
(73%). Chemotherapies were used in ﬁve patients (55%). Two of
them had lymphomas. Two patients had follicular dendritic cell
sarcomas, and another one had squamous cell carcinoma of the
lung. Radiotherapy was applied on one patient (9%) with invasive
lymphoma. Only one patient did not receive any treatment for the
underlying neoplasm because of the huge size of the tumor and
poor general condition.
The prognosis of the patients was dismal. Seven patients in this
study expired. The mortality rate was 64%. Five of them died within
1 year after the diagnosis. One-year overall survival rate was 55%.
Among those who died, the mean duration between the conﬁr-
mation of the diagnosis and death was 10 months. For those who
survived, the mean duration of follow-up was 50 months. All pa-
tients with a conﬁrmed diagnosis of BO passed away rapidly after
development of respiratory symptoms. Two surviving patients had
symptoms of respiratory distress, but none had a conﬁrmed diag-
nosis of BO.
Discussion
In this study, we demonstrated characteristics of PNP patients in
Taiwan. The main ﬁndings of this study are: (1) polymorphic pre-
sentations of clinical and histopathological features are observed in
our patients; (2) the most common associated neoplasm is Cas-
tleman’s disease, followed by malignant thymoma; and (3) a poor
prognosis and a high mortality rate are noted.
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previously reported case series (Table 3). Similar to the design of our
study, Ohyma et al11 and Leger et al12 reported PNP cases based on a
hospital-based or nationwide database without selection for a spe-
ciﬁc associated neoplasm or age groups. The average ages of the
patients in these two studies were similar to our study. Unlike our
study, themost common associated neoplasms of these two studies
were non-Hodgkin’s lymphoma and chronic lymphocytic leukemia,
respectively. Akin to our ﬁndings, polymorphic mucocutaneous
manifestations are also reported in these two studies with
pemphigus-like presentation as the most common mucocutaneous
manifestation. Another case series reported by Choi et al13
describing 12 Korean patients with paraneoplastic pemphigus has
a very similar result regarding the most common associated neo-
plasms (Table 3). However, the most common mucocutaneous pre-
sentation in that study was EM-like lesions rather than pemphigus-
like lesions. Among all studies mentioned above, the mortality rate
and the extents of mucosal lesions are similar except the ocular
involvement, which is less frequently observed in our study.
To clarify the reason for a higher association of Castleman’s
disease in our study, we compared our study with other previously
reported case series with PNP patients of Castleman’s disease.
Minouni et al14 reported 14 cases in children and adolescents, of
which 12 were associated with Castleman’s disease. They
concluded that PNP in children and adolescents is most often a
presenting sign of occult Castleman’s disease. This is consistent
with one of our patients (Case 1), who presented with longstanding
mucocutaneous lesions since his adolescence and a mediastinal
Castleman’s disease complicated with focal follicular dendritic cell
sarcomawas eventually identiﬁed more than 10 years later. Similar
ﬁndings were reported in another two studies reporting PNP cases
exclusively associated with Castleman’s disease.15,16 The average
age in both studies was young. However, only one of the four pa-
tients with Castleman’s disease in our study is young. Therefore,
age of the patients in our study could not account for the higher
association. The possible reason is that there is genetic predispo-
sition because around 77% of PNP patients are associated with
Castleman’s disease in China.16,17 Although the ethnic groups in
Mainland China aremore diverse than those in Taiwan, themajority
of people are Han Chinese in both regions.
LP-like lesions are the main presentations in PNP patients asso-
ciated with Castleman’s disease.13e16 Consistent with this ﬁnding,
three of four patients associated with Castleman’s disease in our
study have LP-like lesions as their main clinical manifestation. InTable 3 Comparison of the present study with previously reported case series of
paraneoplastic pemphigus in the literature.
Present
study
Ohyama
et al11
2001
Leger
et al12
2012
Choi
et al13
2012
Case number 11 21 53 12
Average age (y) 62 51 58 45
The ﬁrst three
most commonly
associated neoplasms
CD
Thymoma
FDCS
NHL
CLL
CD
CLL
NHL
Carcinoma
CD
FDCS
Thymoma
The most common
skin lesion
Pemphigus-
like
Pemphigus-
like
Pemphigus-
like
EM-like
Mucosa involvement
Oral 100 100 89 92
Genital 45 43 51 58
Ocular 36 57 53 58
Respiratory symptom 73 NA NA NA
Mortality rate 64 NA 68 50
Data are presented as % unless otherwise speciﬁed.
CD ¼ Castleman’s disease; CLL ¼ chronic lymphocytic leukemia; EM ¼ erythema
multiforme; FDCS ¼ follicular dendritic cell sarcoma; LP ¼ lichen planus; NA ¼ not
applicable; NHL ¼ non-Hodgkin’s lymphoma.addition, LP-like lesions present in all three patientswere associated
with malignant thymoma in this study and were the predominant
clinical presentations in two of them. Although the association of
pemphigus and thymoma is well established,18 pemphigus-like
presentations are not the main ﬁnding in PNP patients associated
withmalignant thymoma in this study. There are some explanations
for our observations. In addition to pemphigus, several reports have
indicated that thymoma may be associated with LP19,20 and graft-
versus-host-like diseases.21 Moreover, thymoma has been linked
to numerous autoimmune diseases, including myasthenia gravis,
hypogammaglobulinemia, alopecia areata, and pure red cell apla-
sia.22 The fact that thymus is an important immune organ to main-
tain central tolerance may explain the occurrence of immune
dysregulation in the setting of thymic tumors.23 A previous study
provided evidence to support this notion, demonstrating that
circulating CD45RAþCD8þ T cells are signiﬁcantly increased in pa-
tients with thymoma compared with normal controls, and intra-
tumoral T cell development that is abnormally skewed toward the
CD8þ phenotype.24 Therefore, we propose that these abnormal
CD8þ T cells in patients with thymoma may account for the devel-
opment of clinical LP-like presentations and histopathological
lichenoid inﬁltrations in our patients. However, further in-
vestigations are needed to conﬁrm our hypothesis.
The mortality rate of this study was 64%, which is comparable to
the previous reports. Leger et al12 found that the 1-year overall
survival rate was 49%, which was consistent with our observation
that most nonsurvivors died within 1 year after diagnosis. The
development of respiratory symptoms might be the most impor-
tant risk factor for mortality in our study. Six of seven expired pa-
tients had respiratory symptoms, including dry cough and dyspnea.
Four of them had a conﬁrmed diagnosis of BO. In line with our
ﬁnding, pulmonary injury with respiratory failure has been
demonstrated to be the cause of death in most PNP patients asso-
ciated with Castleman’s disease.15 In addition, infections account
for death in the majority of cases in another study,12 which might
have resulted from the use of high dose immunosuppressants.
Indeed, high-dose corticosteroids and/or combined with other
immunosuppressants or immunomodulators were used in all of
our patients. Several episodes of infections were encountered in
our patients as above mentioned. We think that infections work
synergistically with respiratory involvements in these patients
leading to a fatal outcome. In addition to these causes of death, PNP
patients with EM-like skin lesions have been demonstrated to have
amore severe and rapid fatal outcome.12 Four patients with EM-like
presentations in our study did have more refractory courses and all
of them died.
In this study, treatments for PNP and treatments for underlying
neoplasms did not seem to affect the prognosis, which is consistent
with previous studies.12,15 However, a promising outcome has been
reported in a study composed of 22 PNP patients associated with
Castleman’s disease, thymoma, and follicular dendritic cell sar-
coma, who received surgical resections of their neoplasms.25 Only
27% of the patients died in that study. Of note, respiratory symp-
toms persisted in 13 patients. The similar scenario occurred in Case
1 of this study, whose mucocutaneous lesions became stable after
the operation despite the respiratory symptoms persisted. Never-
theless, another of our patients, Case 11, experienced exacerbation
of respiratory symptoms and development of myasthenia gravis
after surgical removal of a malignant thymoma.
Four of our patients had eye involvement. Two of them had
severe corneal perforations and required an amniotic membrane
transplantation. Corneal perforations or melting in PNP patients
have been reported.26,27 The exact mechanism is still undeter-
mined. Both humoral28 and cellular29 mechanisms might be
involved in the pathogenesis of the disease. Although the best
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membrane transplantations are the current standard of treatment
and work well in our patients to prevent symblephara and further
deterioration of visual acuity. Patients with PNP should be moni-
tored for the possibility of eye involvement and evaluate whether
corneal erosion or melting is present. Early identiﬁcation with
prompt management can reduce the risk of irreversible damage of
visual acuity.
In conclusion, to the best of our knowledge, our study is the ﬁrst
case series of PNP in Taiwan and outlines the characteristics of
these patients. Polymorphic mucocutaneous presentations,
frequent associations with Castleman’s disease and malignant
lymphoma, and a poor prognosis with a highmortality rate indicate
that a high clinical suspicion, a thorough investigation for under-
lying neoplasm, and intensive treatments aremandatory tomanage
patients with PNP.
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